UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
JW Pharm discovers novel H4R antagonist for atopic dermatitis
JW Pharmaceuticals Tuesday said it discovered a novel orally available H4R ...
by Marian Chu
|
2018-04-10 17:36
라인
Janssen Korea gets reimbursement for leukemia drug
Janssen Korea said Tuesday that it got the Ministry of Health and Welfare’s...
by Marian Chu
|
2018-04-10 16:14
라인
LG Chem, Merck to co-market hypertension drug
LG Chem and Merck Biopharma Korea said Monday the two firms agreed to sell ...
by So Jae-hyeon
|
2018-04-10 15:15
라인
Il-yang’s ‘Supect’ loses 2nd indication for leukemia
The government said Tuesday Il-yang Pharmaceutical’s Supect (ingredient: ra...
by Lee Hye-seon
|
2018-04-10 15:14
라인
Tamiflu crushed generic copies in flu season
Despite the massive release of generic copies with the expiration of Tamifl...
by So Jae-hyeon
|
2018-04-09 15:40
라인
Biosimilars take on original at breast cancer conference
Industry officials said they were able to witness the advent of biosimilar ...
by So Jae-hyeon
|
2018-04-09 15:05
라인
Boehringer Ingelheim Korea CEO was forced to resign?
Rumors are circulating in the pharmaceutical industry that Park Ki-hwan, CE...
by Nam Doo-hyun
|
2018-04-06 16:10
라인
GC Pharma starts testing anti-EGFR monoclonal antibody
GC Pharma said Thursday that it has launched phase 1b/2a clinical trials fo...
by Lee Han-soo
|
2018-04-05 15:44
라인
Janssen, Hanmi start phase-2 study on obesity, diabetes drug
Janssen and Hanmi Pharmaceutical will start a global phase-2 clinical trial...
by So Jae-hyeon
|
2018-04-05 15:06
라인
Korean biosimilars rarely prescribed in US
Korean biosimilar products are still struggling to penetrate the U.S. marke...
by So Jae-hyeon
|
2018-04-05 15:05
라인
HanAll wins patent for monoclonal antibody in Taiwan
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo
|
2018-04-04 16:07
라인
Will SGLT-2 combos with DPP-4 win insurance coverage?
Suppliers of antidiabetic medicines are paying attention to whether SGLT-2 ...
by So Jae-hyeon
|
2018-04-04 15:12
라인
Outpatient drug prescriptions plunged in February
The outpatient drug prescriptions market saw a drastic contraction in Febru...
by So Jae-hyeon
|
2018-04-03 16:59
라인
Sanofi Genzyme Korea gets go-ahead to market Dupixent
Sanofi Genzyme Korea, the specialty care division of the French pharmaceuti...
by Marian Chu
|
2018-04-03 15:23
라인
Ildong wins patent for retinal diseases biobetter treatment
Ildong Pharmaceutical said Monday that it has acquired a patent regarding t...
by Lee Han-soo
|
2018-04-03 14:35
라인
Seoul orders Janssen to fill up PMS cases to 3,000
Janssen Korea will have to increase the number of post-marketing surveillan...
by Lee Hye-seon
|
2018-04-02 16:30
라인
Boehringer Ingelheim’s COPD therapy may reduce exacerbation risk
Boehringer Ingelheim Korea said Monday that findings from a study of its ch...
by Marian Chu
|
2018-04-02 15:14
라인
Chinese lab ends Olita deal with Hanmi
China’s biotech firm Zai Lab has returned the exclusive sales license of an...
by So Jae-hyeon
|
2018-04-02 11:39
라인
Daewoong, Yuhan in new rivalry to sell antidiabetic drugs
Daewoong Pharmaceutical and Yuhan Corp, both boasting strong marketing powe...
by So Jae-hyeon
|
2018-03-30 16:23
라인
GSK gets nod for shingles vaccine in Europe, Japan
GlaxoSmithKline said Thursday that it snagged approvals from both European ...
by Marian Chu
|
2018-03-29 18:31
-
이전
81
82
83
84
85
86
87
88
89
90
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top